Sponsored content brought to you by As genome sequencing technology advances, researchers are increasingly exploring emerging tools for a host of potential clinical applications. Andrew...
Sponsor: ThermoFisher Scientific VIEW NOW Broadcast Date: June 26, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET Protein structure must be studied in its native cellular environment, otherwise,...
Single-Cell Functional Proteomics Accelerates Immunotherapy Development Opportunities from Pre-Clinical to Clinical Stages
Sponsor: IsoPlexisIsoPlexis’ next generation systems provide actionable potency, safety, and patient difference metrics by detecting highly potent single cell functional subsets for the first time.
Sponsor: Molecular MDCodevelopment is an intermittent and uncertain process. Adopting an agnostic approach to the challenges associated with platform and method selection provide added degrees of freedom for strategic development and selection of the most appropriate clinical trial assay.
Sponsor: Qiagen REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Sponsor: TakedaTakeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.
Sponsor: PerkinElmerRNA and sequencing technologies have the potential to unlock the mystery of our every dynamic transcriptome.
Sponsor: QIAGENThis webinar explores the complexity of diagnostic testing in immuno-oncology and therapeutic innovations that have emerged in the field.
Sponsor: QiagenIn this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.
Sponsor: QIAGENThis groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.